
Trxade Group (MEDS) P/E Ratio
P/E Ratio as of Feb 20, 2026: -0.22
Average-0.2539
Median-0.2500
Minimum-0.2800
Maximum-0.2200
-0.22
0.07 (24.14%)past month
The P/E ratio for Trxade Group (MEDS) is -0.22 as of Feb 20, 2026. This represents a decrease of -15.38% compared to its 12-month average P/E ratio of -0.26. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Trxade Group P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Trxade Group’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Trxade Group to industry peers.
Trxade Group P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Trxade Group’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Trxade Group to industry peers.
Trxade Group (MEDS) P/E Ratio Insights
See Trxade Group’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Trxade Group (MEDS)
Order type
Buy in
Order amount
Est. shares
0 shares
Trxade Group (MEDS) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $0.5525 | -0.31 |
| Nov 3, 2025 | $0.7093 | -0.24 |
| Oct 1, 2025 | $0.8737 | -0.30 |
| Sep 2, 2025 | $0.9771 | -0.33 |
| Aug 1, 2025 | $1.91 | -0.50 |
| Jul 1, 2025 | $1.29 | -0.34 |
| Jun 2, 2025 | $0.88 | -0.23 |
| May 1, 2025 | $0.96 | -0.08 |
| Apr 1, 2025 | $1.34 | -0.12 |
| Mar 3, 2025 | $2.48 | -0.10 |
| Feb 3, 2025 | $3.90 | -0.16 |
| Jan 2, 2025 | $6.0034 | -0.22 |
Trxade Group (MEDS) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.22 | -21.43% |
| 2025 | -0.28 | +27.27% |
| 2024 | -0.22 | -31.25% |
| 2023 | -0.32 | -48.39% |
| 2022 | -0.62 | -72.44% |
| 2021 | -2.25 | — |
FAQs About Trxade Group (MEDS) P/E ratio
The latest P/E ratio of Trxade Group (MEDS) is -0.22, as of Feb 20, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Trxade Group’s last 12-month average P/E ratio is -0.26, compared to its current P/E ratio of -0.22. This reflects a decrease of -15.38%.
Trxade Group’s current P/E ratio of -0.22 is lower than its last 12-month average P/E of -0.26. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Trxade Group’s average P/E ratio over the last 3 years is -0.37. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Trxade Group’s average P/E ratio over the last 5 years is -1.54. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.